MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenkins, B. G.
Right arrow Articles by Lauffer, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, B. G.
Right arrow Articles by Lauffer, R. B.

Detection of site-specific binding and co-binding of ligands to human serum albumin using 19F NMR

BG Jenkins and RB Lauffer

Department of Radiology, Massachusetts General Hospital, Boston.

Binding and co-binding of various 19F-labeled ligands to human serum albumin (HSA) has been studied using 19F NMR. Specifically shifted resonances in slow exchange with the free resonances are detected for many of the ligands. These specifically shifted resonances can be studied to yield accurate estimates of site-specific binding constants and stoichiometries. In addition, the use of two different 19F-labeled ligands can directly reveal competition for a given site or independent binding at different sites. For instance, it is easily shown that both 5-F-L-tryptophan and 5-F-salicylic acid are capable of binding independently to two sites on HSA at the same time, without the need for any curve-fitting or assumptions. These results demonstrate that the concept of "sites" on HSA is not only useful but is necessary. The technique also reveals allosteric interactions between 5-F-L-Trp and warfarin co-bound to HSA. This technique proves to be a powerful methodology for studying ligand and drug binding to HSA that is free from some of the pitfalls associated with more traditional techniques such as equilibrium dialysis.

Volume 37, Issue 1, pp. 111-118, 01/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics